Sensing changes in tumor during boron neutron capture therapy using PET with a collimator: Simulation study
Sign Up to like & getrecommendations! Published in 2020 at "Nuclear Engineering and Technology"
DOI: 10.1016/j.net.2020.02.014
Abstract: Abstract The purpose of this study was to demonstrate the feasibility of sensing changes in a tumor during boron neutron capture therapy (BNCT) using a Monte Carlo simulation tool. In the simulation, an epi-thermal neutron… read more here.
Keywords: neutron; tumor boron; boron neutron; sensing changes ... See more keywords
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2024 at "Hepatology Research"
DOI: 10.1111/hepr.14104
Abstract: When evaluating response to immune checkpoint inhibitor therapy, the tumor sometimes initially swells before shrinking and ultimately responding, also called pseudo‐progression. In this study, we analyzed whether tumor markers were useful for reflecting the treatment… read more here.
Keywords: significance changes; therapy; tumor markers; changes tumor ... See more keywords
Decoding changes in tumor‐infiltrating leukocytes through dynamic experimental models and single‐cell technologies
Sign Up to like & getrecommendations! Published in 2024 at "Immunology and Cell Biology"
DOI: 10.1111/imcb.12787
Abstract: The ability to characterize immune cells and explore the molecular interactions that govern their functions has never been greater, fueled in recent years by the revolutionary advance of single‐cell analysis platforms. However, precisely how immune… read more here.
Keywords: decoding changes; single cell; changes tumor; cell technologies ... See more keywords
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Discovery"
DOI: 10.1158/2159-8290.cd-23-1060
Abstract: Change in cell-free DNA methylomes and fragmentomes after just two cycles of pembrolizumab were associated with progression-free and overall survival in patients with various metastatic cancers, without requiring matched tumor tissue. read more here.
Keywords: tumor naive; cell free; changes tumor; early changes ... See more keywords